Position in PFE
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$27,451
-$4,560 QoQ
Shares Held
1,140
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#2,675
of 2,821 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Field & Main Bank holds $26,958,516 across 8 Drug Manufacturers - General names. PFE ranks #8 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,859 | $9,426,320 | |
| 2 | JNJ |
Johnson & Johnson
|
36,353 | $9,232,570 | |
| 3 | ABBV |
AbbVie Inc.
|
10,715 | $2,696,322 | |
| 4 | AMGN |
Amgen Inc
|
7,076 | $2,562,361 | |
| 5 | MRK |
Merck & Co., Inc.
|
19,053 | $2,448,310 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
9,151 | $527,280 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
300 | $37,902 | |
| 8 | PFE |
Pfizer Inc
This page
|
1,140 | $27,451 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,451 | 1,140 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $32,011 | 1,140 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $28,386 | 1,140 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $29,047 | 1,140 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $31,875 | 1,315 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $37,123 | 1,465 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $30,244 | 1,140 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $32,991 | 1,140 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $43,788 | 1,565 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $46,897 | 1,690 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $189,006 | 6,565 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $367,424 | 11,077 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $429,706 | 11,715 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $471,240 | 11,550 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $538,788 | 10,515 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $417,470 | 9,540 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $494,939 | 9,440 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $330,810 | 6,390 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $299,088 | 5,065 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $217,845 | 5,065 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $206,177 | 5,265 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $188,939 | 5,215 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $193,804 | 5,265 | Shares | Sole | 2021-02-25 | |
| 2020-09-30 | $203,648 | 5,549 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $187,992 | 5,749 | Shares | Sole | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||